In Vivo Oncolytic Virotherapy in Murine Models of Hepatocellular Carcinoma: A Systematic Review

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide. Current therapies often provide marginal survival benefits at the expense of undesirable side effects. Oncolytic viruses represent a novel strategy for the treatment of HCC due to their inherent ability...

Descripción completa

Detalles Bibliográficos
Autores principales: Ailia, Muhammad Joan, Yoo, So Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505175/
https://www.ncbi.nlm.nih.gov/pubmed/36146619
http://dx.doi.org/10.3390/vaccines10091541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505175/
https://www.ncbi.nlm.nih.gov/pubmed/36146619
http://dx.doi.org/10.3390/vaccines10091541

Ejemplares similares